Fezolinetant
- Generic Name
- Fezolinetant
- Brand Names
- Veozah, Veoza
- Drug Type
- Small Molecule
- Chemical Formula
- C16H15FN6OS
- CAS Number
- 1629229-37-3
- Unique Ingredient Identifier
- 83VNE45KXX
- Background
Vasomotor symptoms (VMS), more colloquially known as hot flashes or night sweats, are the most common symptoms, if not the cardinal symptoms, in women. With a median duration of 7.4 years, vasomotor symptoms are also the most common reasons why women seek treatments for menopausal issues. Although mostly considered a nuisance, vasomotor symptoms could potent...
- Indication
Fezolinetant is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause.
- Associated Conditions
- Moderate to Severe Vasomotor Symptoms
- Associated Therapies
- -
No news found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath